JP2011512134A5 - - Google Patents

Download PDF

Info

Publication number
JP2011512134A5
JP2011512134A5 JP2010546400A JP2010546400A JP2011512134A5 JP 2011512134 A5 JP2011512134 A5 JP 2011512134A5 JP 2010546400 A JP2010546400 A JP 2010546400A JP 2010546400 A JP2010546400 A JP 2010546400A JP 2011512134 A5 JP2011512134 A5 JP 2011512134A5
Authority
JP
Japan
Prior art keywords
peptide linker
motif
polypeptides
modified
fusion polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2010546400A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011512134A (ja
Filing date
Publication date
Priority claimed from GB0802978A external-priority patent/GB0802978D0/en
Priority claimed from GB0821076A external-priority patent/GB0821076D0/en
Priority claimed from GB0900539A external-priority patent/GB0900539D0/en
Application filed filed Critical
Priority claimed from PCT/GB2009/000437 external-priority patent/WO2009103965A1/en
Publication of JP2011512134A publication Critical patent/JP2011512134A/ja
Publication of JP2011512134A5 publication Critical patent/JP2011512134A5/ja
Withdrawn legal-status Critical Current

Links

JP2010546400A 2008-02-19 2009-02-18 修飾リンカー Withdrawn JP2011512134A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0802978A GB0802978D0 (en) 2008-02-19 2008-02-19 Modified linkers
GB0821076A GB0821076D0 (en) 2008-11-19 2008-11-19 Modified linkers
GB0900539A GB0900539D0 (en) 2009-01-14 2009-01-14 Modified linkers
PCT/GB2009/000437 WO2009103965A1 (en) 2008-02-19 2009-02-18 Modified linkers

Publications (2)

Publication Number Publication Date
JP2011512134A JP2011512134A (ja) 2011-04-21
JP2011512134A5 true JP2011512134A5 (https=) 2012-04-12

Family

ID=40845701

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010546400A Withdrawn JP2011512134A (ja) 2008-02-19 2009-02-18 修飾リンカー

Country Status (4)

Country Link
US (1) US20110172165A1 (https=)
EP (1) EP2288386A1 (https=)
JP (1) JP2011512134A (https=)
WO (1) WO2009103965A1 (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0719818D0 (en) * 2007-10-11 2007-11-21 Asterion Ltd Growth hormone fusion polypeptides
DK2406289T3 (en) * 2009-03-10 2017-05-01 Baylor Res Inst ANTIGEN PRESENTING CELL TARGETED ANTIVIRUS VACCINES
EP2553101A4 (en) * 2010-04-02 2013-09-04 Univ Rochester PROTEASE-ACTIVATED CYTOKINES
AU2012302636B2 (en) 2011-09-04 2016-09-15 Glytech, Inc. Glycosylated polypeptide and drug composition containing said polypeptide
BR112014004936A2 (pt) * 2011-09-04 2017-04-04 Glytech Inc polipeptídeo glicosilado e composição de drogas contendo referido polipeptídeo
EP2732824A1 (en) * 2012-11-16 2014-05-21 Ceva Sante Animale Compositions and methods for increasing reproduction performance in non human mammals using alpha-beta-linked follicle stimulating hormone
EP3068891A1 (en) * 2013-11-13 2016-09-21 Aequus Biopharma Inc. Engineered glycoproteins and uses thereof
CN114853873B (zh) * 2015-06-11 2025-01-28 格纳西尼有限公司 经修饰的白细胞介素-7蛋白及其用途
EP3746103A4 (en) 2017-12-06 2022-03-30 The Board of Trustees of the Leland Stanford Junior University PROTEINS ENGINEERED TO INCREASE A CELL'S SENSITIVITY TO IL-2
PE20210313A1 (es) * 2018-03-28 2021-02-12 Bristol Myers Squibb Co Proteinas de fusion interleucina-2/receptor alfa de interleucina-2 y metodos de uso
WO2019222296A1 (en) 2018-05-14 2019-11-21 Werewolf Therapeutics, Inc. Activatable interleukin 12 polypeptides and methods of use thereof
AU2019271148B9 (en) 2018-05-14 2025-05-29 Werewolf Therapeutics, Inc. Activatable interleukin-2 polypeptides and methods of use thereof
EP3969035A4 (en) 2019-05-14 2023-06-21 Werewolf Therapeutics, Inc. SEPARATION UNITS AND METHODS AND THEIR USE
MX2022005666A (es) 2019-11-14 2022-10-07 Werewolf Therapeutics Inc Polipeptidos de citocina activables y metodos de uso de los mismos.
WO2021127487A2 (en) 2019-12-20 2021-06-24 Regeneron Pharmaceuticals, Inc. Novel il2 agonists and methods of use thereof
WO2021247474A1 (en) * 2020-06-02 2021-12-09 H. Lee Moffitt Cancer Center And Research Institute Inc. Sstr-binding chimeric antigen receptors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5000800A (en) * 1999-05-10 2000-11-21 Salk Institute For Biological Studies, The Constitutive chimeric receptors, and methods of use thereof
EP1290170A2 (en) * 2000-06-16 2003-03-12 Asterion Limited Binding agents: chimeric ligand/receptor proteins
EP1771467A2 (en) * 2004-07-26 2007-04-11 Asterion Limited Linkers

Similar Documents

Publication Publication Date Title
JP2011512134A5 (https=)
DK2035447T3 (da) Polypeptid
IL218296A0 (en) Obpgplys/endolysin polypeptides, fusion proteins and compositions compriisng the same and uses thereof
JP2011506530A5 (https=)
JP2011520976A5 (https=)
LTPA2017029I1 (lt) Rekombinantinis FSH, įskaitant alfa 2,3- ir alfa 2,6-sialilinimą
JP2010143932A5 (https=)
JP2011508438A5 (https=)
DK2378921T4 (da) Sammensat element, multilagsplade og panelformet element til at danne det sammensatte element
PL2173381T3 (pl) Polipeptydy o zmodyfikowanych funkcjach efektorowych wiążące się z receptorem Fc
JP2013523703A5 (https=)
JP2011501007A5 (https=)
JP2011526809A5 (https=)
CR10523A (es) Cepa bg1 de thermoanaerobacter mathranii
JP2010505891A5 (https=)
EP2558306A4 (en) DIGITAL INJECTED DESIGN IN POWDER SURFACES
WO2006131564A3 (de) Neue cystein-verarmte hydrophobinfusionsproteine, deren herstellung und verwendung
SG172333A1 (en) Monoclonal antibodies specific to the fusion peptide from hemagglutinin from influenza a viruses and uses thereof
WO2007115724A3 (en) Method of increasing the in vivo recovery of therapeutic polypeptides
IL209304A0 (en) Peptides, peptidomimetics and derivatives thereof, the manufacturing thereof as well as their use for preparing a therapeutically and/or preventively active pharmaceutical composition
WO2009081170A3 (en) Peptide fusion proteins
FR2919317B1 (fr) Entrevous leger a paroi mince.
JP2011040210A5 (https=)
JP2012501322A5 (https=)
JP2008545704A5 (https=)